Cannabis firm Cronos inks $122 million deal to produce lab-grown cannabinoids

Canadian cannabis producer Cronos Group has tapped Boston-based Ginkgo Bioworks in a $122 million endeavor to biologically engineer a wide range of cannabinoids found in cannabis. Under the deal, announced Tuesday,¬†Ginkgo, which creates customized microbes, will work exclusively with Cronos to research and design microorganisms capable of producing cannabinoids. According to a Cronos news release, […] Cannabis firm Cronos inks $122 million deal to produce lab-grown cannabinoids is a post from: Marijuana Business Daily: Financial, Legal & Cannabusiness news for cannabis entrepreneurs